ATE448793T1 - Rekombinante hybrid-allergenkonstrukte mit verringerter allergenität unter beibehaltung der immunogenität des natürlichen allergens - Google Patents

Rekombinante hybrid-allergenkonstrukte mit verringerter allergenität unter beibehaltung der immunogenität des natürlichen allergens

Info

Publication number
ATE448793T1
ATE448793T1 AT02713767T AT02713767T ATE448793T1 AT E448793 T1 ATE448793 T1 AT E448793T1 AT 02713767 T AT02713767 T AT 02713767T AT 02713767 T AT02713767 T AT 02713767T AT E448793 T1 ATE448793 T1 AT E448793T1
Authority
AT
Austria
Prior art keywords
allergen
immunogenicity
allergenity
constructs
maintaining
Prior art date
Application number
AT02713767T
Other languages
English (en)
Inventor
Te King
Michael Spangfort
Original Assignee
Univ Rockefeller
Alk Abello As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Rockefeller, Alk Abello As filed Critical Univ Rockefeller
Application granted granted Critical
Publication of ATE448793T1 publication Critical patent/ATE448793T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • C07K14/43563—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from insects
    • C07K14/43568—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from insects from wasps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62—DNA sequences coding for fusion proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2299/00—Coordinates from 3D structures of peptides, e.g. proteins or enzymes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/20—Fusion polypeptide containing a tag with affinity for a non-protein ligand
    • C07K2319/21—Fusion polypeptide containing a tag with affinity for a non-protein ligand containing a His-tag
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/40—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Insects & Arthropods (AREA)
  • Toxicology (AREA)
  • Physics & Mathematics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Pulmonology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT02713767T 2001-03-02 2002-03-04 Rekombinante hybrid-allergenkonstrukte mit verringerter allergenität unter beibehaltung der immunogenität des natürlichen allergens ATE448793T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US27281801P 2001-03-02 2001-03-02
PCT/US2002/006765 WO2002070665A2 (en) 2001-03-02 2002-03-04 Recombinant hybrid allergen constructs with reduced allergenicity that retain immunogenicity of the natural allergen

Publications (1)

Publication Number Publication Date
ATE448793T1 true ATE448793T1 (de) 2009-12-15

Family

ID=23041432

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02713767T ATE448793T1 (de) 2001-03-02 2002-03-04 Rekombinante hybrid-allergenkonstrukte mit verringerter allergenität unter beibehaltung der immunogenität des natürlichen allergens

Country Status (9)

Country Link
US (1) US20030039660A1 (de)
EP (1) EP1499349B1 (de)
JP (1) JP2005508134A (de)
CN (1) CN1610556A (de)
AT (1) ATE448793T1 (de)
CA (1) CA2441476A1 (de)
DE (1) DE60234475D1 (de)
DK (1) DK1499349T3 (de)
WO (1) WO2002070665A2 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7384635B2 (en) * 2002-11-01 2008-06-10 Alk-Abello A/S Protein variants of naturally occurring allergens
JP4463198B2 (ja) * 2003-03-05 2010-05-12 財団法人化学及血清療法研究所 大腸菌における異種蛋白質の製造方法
EP1680446B1 (de) * 2003-11-05 2007-10-31 Pevion Biotech Ltd. Zusammensetzungen, die von melittin abgeleitet sind und peptide enthalten, und verfahren zur potenzierung von immunreaktionen gegen target-antigene
PL1868642T3 (pl) 2005-03-18 2013-10-31 Cytos Biotechnology Ag Białka fuzyjne alergenów kocich i ich zastosowania
EP2692732A1 (de) 2012-08-03 2014-02-05 Stallergenes S.A. Neues Allergen aus Kreuzkrautpollen und Verwendung davon
US10799573B2 (en) * 2016-03-30 2020-10-13 Regents Of The University Of Minnesota Pertussis vaccines and methods of making and using
CN112654711B (zh) * 2018-08-29 2024-03-26 上海科技大学 Cas蛋白抑制剂的组合物及应用
EP4106534A4 (de) * 2020-02-19 2024-03-27 Perfect Day, Inc. Hypoallergene rekombinante milchproteine und zusammensetzungen damit
CN113173982B (zh) * 2021-04-14 2022-09-06 中国海洋大学 Rap v 2蛋白相关的抗原表位肽及其应用
CN114685636B (zh) * 2022-03-04 2024-03-01 首都医科大学附属北京同仁医院 蒿属植物花粉过敏原、应用及试剂盒
CN120757635A (zh) * 2025-07-03 2025-10-10 暨南大学 一种拟柱孢藻毒素基因工程抗体的制备及评价方法

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5091309A (en) 1986-01-16 1992-02-25 Washington University Sindbis virus vectors
US5354844A (en) 1989-03-16 1994-10-11 Boehringer Ingelheim International Gmbh Protein-polycation conjugates
US5703055A (en) 1989-03-21 1997-12-30 Wisconsin Alumni Research Foundation Generation of antibodies through lipid mediated DNA delivery
US5264618A (en) 1990-04-19 1993-11-23 Vical, Inc. Cationic lipids for intracellular delivery of biologically active molecules
KR100372934B1 (ko) 1990-09-25 2003-12-24 캔탑 파마슈티칼스 리서취 리미티드 형질 상보성 세포주에 의해 생성된 바이러스 결손 백신
US5593877A (en) 1993-03-11 1997-01-14 The Rockefeller University Nucleic acid and recombinant production of vespid venom hyaluronidase
WO1994021807A2 (en) 1993-03-19 1994-09-29 Cantab Pharmaceuticals Research Limited Defective mutant non-retroviral virus (e.g. hsv) as vaccine
FR2714830B1 (fr) 1994-01-10 1996-03-22 Rhone Poulenc Rorer Sa Composition contenant des acides nucléiques, préparation et utilisations.
FR2715847B1 (fr) 1994-02-08 1996-04-12 Rhone Poulenc Rorer Sa Composition contenant des acides nucléiques, préparation et utilisations.
EP0753069A1 (de) 1994-04-15 1997-01-15 Targeted Genetics Corporation Fusionsprotein für Gentransfer
FR2727679B1 (fr) 1994-12-05 1997-01-03 Rhone Poulenc Rorer Sa Nouveaux agents de transfection et leurs applications pharmaceutiques
FR2730637B1 (fr) 1995-02-17 1997-03-28 Rhone Poulenc Rorer Sa Composition pharmaceutique contenant des acides nucleiques, et ses utilisations
US5804201A (en) 1996-03-11 1998-09-08 The Rockefeller University Immunomodulatory peptides of vespid antigen 5
US6432699B1 (en) 1997-03-28 2002-08-13 New York University Viral vectors having chimeric envelope proteins containing the IgG-binding domain of protein A
IL133708A0 (en) 1997-06-30 2001-04-30 Rhone Poulence Rorer S A Improved method for transferring nucleic acid into multicelled eukaryotic organism cells and combination thereof
DE69826124T3 (de) 1997-06-30 2007-10-11 Institut Gustave Roussy Verabreichung der nukleinsäure in den quergestreiften muskel
IL133709A0 (en) 1997-06-30 2001-04-30 Rhone Poulence Rorer S A Device for optimized electrotransfer of nucleic acid vectors to tissues in vivo
ATE408690T1 (de) * 1998-03-16 2008-10-15 Alk Abello As Mutiertes rekombinantes allergen
AU2631501A (en) * 2000-01-06 2001-07-16 Monsanto Technology Llc Preparation of deallergenized proteins and permuteins
US7384635B2 (en) * 2002-11-01 2008-06-10 Alk-Abello A/S Protein variants of naturally occurring allergens

Also Published As

Publication number Publication date
DE60234475D1 (de) 2009-12-31
EP1499349A2 (de) 2005-01-26
DK1499349T3 (da) 2010-04-06
CN1610556A (zh) 2005-04-27
WO2002070665A2 (en) 2002-09-12
US20030039660A1 (en) 2003-02-27
CA2441476A1 (en) 2002-09-12
WO2002070665A8 (en) 2004-12-16
EP1499349A4 (de) 2005-11-16
EP1499349B1 (de) 2009-11-18
WO2002070665A3 (en) 2004-11-11
JP2005508134A (ja) 2005-03-31

Similar Documents

Publication Publication Date Title
EP1847549A3 (de) Polyproteinkonstrukte des Papillomavirus
MXPA05013526A (es) Secuencias de acido nucleico que codifican y composiciones que comprenden el peptido de senal de ige y/o il-15 y metodos para uso de los mismos.
ATE557041T1 (de) Peptid-vakzinen gegen streptokokken der gruppe a
DK1194560T3 (da) Antigene Neisseria-peptider
ATE454393T1 (de) Egvii-endoglucanase und dafür codierende nukleinsäuren
DE60039050D1 (de) Antigene meningokokken peptide
DE50112802D1 (de) Peptide, deren herstellung und verwendung zur bindung von immunglobulinen
DE60234475D1 (de) Rekombinante hybrid-allergenkonstrukte mit verringerter allergenität unter beibehaltung der immunogenität des natürlichen allergens
WO2002008277A3 (en) Nucleic acids, vectors, host cells, polypeptides, and uses thereof
DE60331224D1 (de) Subtilisin-carlsberg-proteine mit verminderter immunogenität
DE60335726D1 (de) Chromoprotein und fluoroproteine
DE69836744D1 (de) Gruppe a streptokokken-impfstoff
ATE477272T1 (de) Verwendung von stefin a als gerüstprotein
ATE469655T1 (de) Bakteriophagenvermittelte impfung
ATE412745T1 (de) Antiangiogene peptide vom n-terminus von endostatin
DE602004028266D1 (de) Angiogene peptide und ihre verwendungen
ATE397081T1 (de) Erhöhte expression von proteinen mittels gfp
ATE414099T1 (de) Biologisch aktive peptide
DE69935599D1 (de) Modifizierte hcv peptid-impfstoffe
IL173954A0 (en) Libraries of recombinant chimeric proteins and methods of generating the same
DE60142356D1 (de) 18480 humane proteinkinasemoleküle und ihre verwendungen
DE60237236D1 (de) Ein mitglied der menschlichen proteinkinasefamilie, und verwendungen dafür
DE60330256D1 (de) Bakteriophagen-vermittelte immunisierung gegen hepatitis
DE60120391D1 (de) Verwendung von hev-polypeptiden
DE60129228D1 (de) Humane 7-transmembranproteine und dafür codierende polynukleotide

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties